Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
05/20/1992 | EP0485563A1 Polyether-substituted tumor agents. |
05/20/1992 | EP0485530A1 TGF-$g(b) PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
05/20/1992 | EP0485497A1 Il-2 deletion mutants |
05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
05/20/1992 | EP0485434A1 Shelf stable aspirin solutions |
05/20/1992 | EP0287646B1 Cosmetic preparations containing ubidecarenones |
05/20/1992 | EP0274467B1 Hepatocyte directed vesicle delivery system |
05/20/1992 | EP0225367B1 Film forming composition for topical use |
05/19/1992 | US5114956 Parenteral formulation of nimodipine |
05/19/1992 | US5114948 Oxidation resistance by adding methionine, cysteine, or cysteine hydrochloride |
05/19/1992 | US5114946 An enantiomorphs and a vehicle for drug deliversy |
05/19/1992 | US5114931 Antilipemic agents, atheriosclerosis or antidepressants |
05/19/1992 | US5114928 Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
05/19/1992 | US5114707 Curable polysiloxanes oils for release of iodine |
05/19/1992 | CA1301068C Glycosaminoglycan and cationic polymer combinations |
05/19/1992 | CA1301066C Anti-tumour substance and process for producing the same |
05/17/1992 | WO1992008373A1 Semduramicin premix |
05/16/1992 | CA2055681A1 Complexes containing s(+) phenyl alkane acids and amino sugars |
05/16/1992 | CA2055578A1 Aqueous gel with retinoic acid and hydroxypropyl-.beta.-cyclodextrine, and use thereof in human medicine and cosmetic applications |
05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
05/15/1992 | CA2055115A1 A process for preparing a pharmaceutical composition |
05/14/1992 | WO1992008445A1 Non-aqueous microemulsion for drug delivery |
05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
05/14/1992 | WO1992007920A1 Improved processes for the manufacture of enriched pitches and carbon fibers |
05/14/1992 | WO1992007589A1 Transdermal contraceptive formulations, methods and devices |
05/14/1992 | WO1992007586A1 Topical composition with retinoid penetration enhancer |
05/14/1992 | WO1992007574A1 Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells |
05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
05/14/1992 | WO1992007555A1 Drug delivery system and method |
05/14/1992 | WO1992007552A1 Lyophilized preparation and production thereof |
05/14/1992 | WO1992007551A1 Process for producing fat emulsion |
05/14/1992 | WO1992007543A1 Oil-in-water emulsions |
05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
05/14/1992 | WO1991018911A3 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
05/14/1992 | CA2095819A1 Non-aqueous microemulsion for drug delivery |
05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
05/14/1992 | CA2094935A1 Oil-in-water emulsions |
05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
05/13/1992 | EP0485251A1 Cosmetic, pharmaceutical or alimentary composition comprising a dispersion of lipid vesicles |
05/13/1992 | EP0485173A2 Esters and amides of substituted fused ring phenyl acetic acids |
05/13/1992 | EP0485171A2 Esters and amides of substituted phenyl and pyridyl amino carboxylates |
05/13/1992 | EP0485158A2 Esters and amides of substituted phenyl acetic acids |
05/13/1992 | EP0485157A2 Esters and amides of substituted pyrrole acetic acids |
05/13/1992 | EP0484936A1 Suspensions containing tricyclic compounds |
05/13/1992 | EP0484870A2 Prodrugs for beta-lactamase and uses thereof |
05/13/1992 | EP0484857A2 Polyorganosiloxane having a quaternary salt at its one terminal and percutaneous absorption-promoting agent |
05/13/1992 | EP0484529A1 Skin cream preparation for external use |
05/13/1992 | EP0484403A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
05/13/1992 | EP0446299A4 Method for site-specifically incorporating unnatural amino acids into proteins |
05/13/1992 | EP0214299B1 Preparation of 5-fluoro-2'-deoxyuridine esters for intraarterial administration |
05/13/1992 | EP0174377B2 W/o/w complex emulsion for medicinal or cosmetic use |
05/13/1992 | CN1060962A Composition containing ephedrine base and alkyl salicylate for delivery of ephedrine hase in vapor form |
05/13/1992 | CN1060948A Nutritional composition and process for its production |
05/12/1992 | US5112954 Antibodies specific for cancer cells |
05/12/1992 | US5112953 Radiolabeled proteins for diagnostic or therapeutic use |
05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
05/12/1992 | US5112844 Micelles |
05/12/1992 | US5112816 Corticorsteroid-containing ointments |
05/12/1992 | US5112813 Alginates |
05/12/1992 | US5112804 Glycyrrhetinic acid promotes absorption |
05/12/1992 | US5112739 Quinone-methide elimination |
05/12/1992 | US5112621 Sustained release pharmaceutical composition of diltiazem |
05/12/1992 | US5112620 Blend of polyether and water soluble salt of maleic acid or anhydride copolymer with methyl vinyl ether with anesthetic and steroid |
05/12/1992 | US5112615 Soluble hirudin conjugates |
05/12/1992 | US5112608 Use of protease nexin-I to mediate wound healing |
05/12/1992 | US5112607 Potentiation of immunotoxin action by Brefeldin A |
05/12/1992 | US5112601 Alkyl esters of n-carboalkyloxy amino-11-undecanoic acids, their use as thickening agents |
05/12/1992 | US5112598 Vitamin a aerosol-inhalate preparations |
05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
05/12/1992 | US5112515 Phenothrin shampoo |
05/12/1992 | US5112305 Catheter device for intramural delivery of therapeutic agents |
05/12/1992 | CA1300611C Method for the preparation of an acidic dicarboxylic acid ester of cellulose ether |
05/12/1992 | CA1300515C Pharmaceutical composition for treating periodontal diseases |
05/12/1992 | CA1300510C Stabilized composition containing angiotensin converting enzyme |
05/12/1992 | CA1300508C Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease |
05/12/1992 | CA1300493C Radiation compatible iodine formulation |
05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
05/10/1992 | WO1992008449A1 Procaterol-containing plaster |
05/10/1992 | CA2073254A1 Procaterol-containing preparation for application to the skin |
05/10/1992 | CA2055180A1 Aerosol composition and a process preparing same |
05/09/1992 | CA2095123A1 Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
05/09/1992 | CA2054983A1 Suspendible composition and process for preparing the same |
05/07/1992 | WO1992007571A1 Process for producing fat emulsion |
05/07/1992 | CA2055062A1 Prodrugs for beta-lactamase and uses thereof |
05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
05/06/1992 | EP0484186A1 Formulations and their use in the treatment of neurological diseases |
05/06/1992 | EP0484148A1 A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines |
05/06/1992 | EP0484112A2 Use of lithium in the treatment or prophylaxis of Molluscum contagiosum |
05/06/1992 | EP0484106A1 Controlled release formulations |
05/06/1992 | EP0483854A1 Fatty emulsion |
05/06/1992 | EP0483213A1 Transdermal administration of lisuride |
05/06/1992 | EP0302900B1 Taste-masked pharmaceutical compositions |
05/06/1992 | CN1060851A Prolonged release preparation and polymers thereof |
05/05/1992 | US5110929 Quaternization of pyrazine compounds |
05/05/1992 | US5110909 Both covalent and ionic bonding with ligand attached to polymer |
05/05/1992 | US5110814 Azelastine and its salts used to combat psoriasis |
05/05/1992 | US5110809 Sulconazole nitrate, hydroxycortisone valerate, cosolvent alcohols, hydroxyalkyl cellulose |
05/05/1992 | US5110606 Solution of drug in nonaqueous solvent dispersed in fatty acid ester |
05/05/1992 | US5110602 Solution or suspension in middle chain glyceride to inhibit degradation by digestive enzymes |